Image-Guided Neurologics and Peregrine Pharmaceuticals Agree to Study Use Of Navigus(R) Array Catheter in Treatment of Brain Cancer
Image-Guided Neurologics, a medical device company developing access and navigational products for minimally invasive neurosurgery techniques, and Peregrine Pharmaceuticals, Inc., have agreed to co-sponsor a Phase I/II pilot study for Cotara(TM), Peregrine`s Tumor Necrosis Therapy drug, that utilizes IGN`s Navigus(R) Array multi-lumen intracranial catheter in patients with brain cancer.
Aug 22 7:45 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010822/mnw004.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines